Physician profile
Amanda Macfie
NPI 1578331799
$432.69
in general payments reported to CMS, 2019-2025
12 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $216 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $82.14 | 2024-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.76 | 2024-2025 | Xifaxan |
| Axsome Therapeutics, INC. | $68.19 | 2024-2025 | Auvelity |
| Astrazeneca Pharmaceuticals Lp | $35.91 | 2024-2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $29.91 | 2024-2025 | Cologuard Collection Kit |
| Stryker Corporation | $26.70 | 2025 | Clottriever Bold Catheter |
| Astellas Pharma US INC | $23.86 | 2024 | Veozah |
| Lilly USA, LLC | $22.13 | 2024 | Zepbound, Mounjaro |
| Amgen INC. | $20.57 | 2025 | Prolia, Xgeva, Evenity |
| Glaxosmithkline, LLC. | $20.12 | 2025 | Trelegy Ellipta |
| Globus Medical, INC. | $17.07 | 2025 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $16.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Macfie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.